Skip to Content

Publications

Leading gifts lay groundwork for Moon Shots Program

Promise - Spring 2013

MD Anderson’s Moon Shots Program, an aggressive, milestone-driven effort initially targeting eight cancers, relies on private philanthropy as a crucial source of funding. Leading contributors to date include:

  • Lyda Hill: $50 million,
  • The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation: $10 million to the Center for Co-Clinical Trials and the Translational Research Continuum platforms,
  • C.G. Johnson Estate: $10 million,
  • The Cullen Trust for Health Care: $2 million to the Center for Co-Clinical Trials and the Translational Research Continuum platforms,
  • Mr. and Mrs. William J. Kyte: $2 million to the lung cancer moon shot, and
  • The John G. and Marie Stella Kenedy Memorial Foundation: $1.5 million.

The Moon Shots Program aims to dramatically reduce deaths initially from:

  • acute myeloid leukemia and myelodysplastic syndrome,
  • chronic lymphocytic leukemia,
  • melanoma,
  • lung cancer,
  • prostate cancer, and
  • triple-negative breast and ovarian cancers.

Each moon shot will receive funds and other resources to pursue innovative projects prioritized for greatest patient impact. Specialized platforms will provide infrastructure, technologies or processes that will support all of the moon shots. The goal is to ultimately apply knowledge gained from this process to all cancers.

Make a difference

Your gift to MD Anderson makes a difference in the lives of cancer patients by supporting innovative patient care, research, education and prevention programs. You can Donate Now or learn more at myGiving to MD Anderson.

© 2014 The University of Texas MD Anderson Cancer Center